206 related articles for article (PubMed ID: 35750461)
41. Effects of a Six-Month Multi-Ingredient Nutrition Supplement Intervention of Omega-3 Polyunsaturated Fatty Acids, vitamin D, Resveratrol, and Whey Protein on Cognitive Function in Older Adults: A Randomised, Double-Blind, Controlled Trial.
Moran C; Scotto di Palumbo A; Bramham J; Moran A; Rooney B; De Vito G; Egan B
J Prev Alzheimers Dis; 2018; 5(3):175-183. PubMed ID: 29972210
[TBL] [Abstract][Full Text] [Related]
42. A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2).
Crabb S; Morgan A; Hunter MS; Stefanopoulou E; Griffiths G; Richardson A; Fenlon D; Fleure L; Raftery J; Boxall C; Wilding S; Nuttall J; Eminton Z; Tilt E; O'Neill A; Bacon R; Martin J
Trials; 2023 Jul; 24(1):450. PubMed ID: 37430353
[TBL] [Abstract][Full Text] [Related]
43. Home-based versus supervised group exercise in men with prostate cancer on androgen deprivation therapy: A randomized controlled trial and economic analysis.
Alibhai SMH; Papadopoulos E; Mina DS; Ritvo P; Tomlinson G; Sabiston CM; Durbano S; Bremner KE; Chiarotto J; Matthew A; Warde P; O'Neill M; Culos-Reed SN
J Geriatr Oncol; 2024 Jan; 15(1):101646. PubMed ID: 37976654
[TBL] [Abstract][Full Text] [Related]
44. Examining the effects of creatine supplementation in augmenting adaptations to resistance training in patients with prostate cancer undergoing androgen deprivation therapy: a randomised, double-blind, placebo-controlled trial.
Fairman CM; Kendall KL; Newton RU; Hart NH; Taaffe DR; Chee R; Tang CI; Galvão DA
BMJ Open; 2019 Sep; 9(9):e030080. PubMed ID: 31542747
[TBL] [Abstract][Full Text] [Related]
45. Transdermal oestradiol and exercise in androgen deprivation therapy (ESTRACISE): protocol.
Jussila I; Ahtiainen JP; Laakkonen EK; Siltari A; Kaipia A; Jokela T; Kärkkäinen M; Newton R; Raastad T; Huhtala H; Murtola TJ; Seikkula H
BJU Int; 2024 Jul; 134(1):110-118. PubMed ID: 38587276
[TBL] [Abstract][Full Text] [Related]
46. Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review.
Bressi B; Cagliari M; Contesini M; Mazzini E; Bergamaschi FAM; Moscato A; Bassi MC; Costi S
Support Care Cancer; 2021 Apr; 29(4):1811-1824. PubMed ID: 33119791
[TBL] [Abstract][Full Text] [Related]
47. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2014 Sep; 15(10):1076-89. PubMed ID: 25130995
[TBL] [Abstract][Full Text] [Related]
48. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.
Newton RU; Taaffe DR; Spry N; Gardiner RA; Levin G; Wall B; Joseph D; Chambers SK; Galvão DA
BMC Cancer; 2009 Jun; 9():210. PubMed ID: 19563641
[TBL] [Abstract][Full Text] [Related]
49. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
[TBL] [Abstract][Full Text] [Related]
50. Feasibility and safety of physical exercise in men with prostate cancer receiving androgen deprivation therapy and radiotherapy: a study protocol.
Bressi B; Iotti C; Cagliari M; Cavuto S; Fugazzaro S; Costi S
BMJ Open; 2022 Mar; 12(3):e048854. PubMed ID: 35292485
[TBL] [Abstract][Full Text] [Related]
51. Effects of a multi-modal resistance exercise program and calcium-vitamin D
Foulkes S; Kukuljan S; Nowson CA; Sanders KM; Daly RM
Eur J Nutr; 2021 Apr; 60(3):1289-1299. PubMed ID: 32666313
[TBL] [Abstract][Full Text] [Related]
52. Mediterranean-style dietary pattern improves cancer-related fatigue and quality of life in men with prostate cancer treated with androgen deprivation therapy: A pilot randomised control trial.
Baguley BJ; Skinner TL; Jenkins DG; Wright ORL
Clin Nutr; 2021 Jan; 40(1):245-254. PubMed ID: 32534948
[TBL] [Abstract][Full Text] [Related]
53. A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
Alibhai SM; Santa Mina D; Ritvo P; Sabiston C; Krahn M; Tomlinson G; Matthew A; Segal R; Warde P; Durbano S; O'Neill M; Culos-Reed N
BMC Cancer; 2015 Apr; 15():312. PubMed ID: 25908311
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial.
Uth J; Hornstrup T; Christensen JF; Christensen KB; Jørgensen NR; Schmidt JF; Brasso K; Jakobsen MD; Sundstrup E; Andersen LL; Rørth M; Midtgaard J; Krustrup P; Helge EW
Osteoporos Int; 2016 Apr; 27(4):1507-1518. PubMed ID: 26572756
[TBL] [Abstract][Full Text] [Related]
55. Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.
Wall BA; GALVãO DA; Fatehee N; Taaffe DR; Spry N; Joseph D; Hebert JJ; Newton RU
Med Sci Sports Exerc; 2017 Aug; 49(8):1503-1510. PubMed ID: 28319589
[TBL] [Abstract][Full Text] [Related]
56. Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trial.
Hackshaw-McGeagh L; Lane JA; Persad R; Gillatt D; Holly JM; Koupparis A; Rowe E; Johnston L; Cloete J; Shiridzinomwa C; Abrams P; Penfold CM; Bahl A; Oxley J; Perks CM; Martin R
Trials; 2016 Mar; 17(1):123. PubMed ID: 26948468
[TBL] [Abstract][Full Text] [Related]
57. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer.
Alberga AS; Segal RJ; Reid RD; Scott CG; Sigal RJ; Khandwala F; Jaffey J; Wells GA; Kenny GP
Support Care Cancer; 2012 May; 20(5):971-81. PubMed ID: 21538098
[TBL] [Abstract][Full Text] [Related]
58. Combined effects of vitamin D supplementation and endurance exercise training on insulin resistance in newly diagnosed type 2 diabetes mellitus patients with vitamin D deficiency: study protocol for a randomized controlled trial.
Xiang M; Sun X; Wei J; Cao ZB
Trials; 2021 Dec; 22(1):888. PubMed ID: 34872610
[TBL] [Abstract][Full Text] [Related]
59. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
Denham JW; Wilcox C; Joseph D; Spry NA; Lamb DS; Tai KH; Matthews J; Atkinson C; Turner S; Christie D; Gogna NK; Kenny L; Duchesne G; Delahunt B; McElduff P
Lancet Oncol; 2012 Dec; 13(12):1260-70. PubMed ID: 23151431
[TBL] [Abstract][Full Text] [Related]
60. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life.
Rutjes AW; Denton DA; Di Nisio M; Chong LY; Abraham RP; Al-Assaf AS; Anderson JL; Malik MA; Vernooij RW; Martínez G; Tabet N; McCleery J
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011906. PubMed ID: 30556597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
